Publicaciones (42) Publicaciones de MARÍA LUZ HERNÁNDEZ GÁLVEZ

2017

  1. Altered striatal endocannabinoid signaling in a transgenic mouse model of spinocerebellar ataxia type-3

    PLoS ONE, Vol. 12, Núm. 4

  2. Modeling Neurodegenerative Disorders for Developing Cannabinoid-Based Neuroprotective Therapies

    Methods in Enzymology (Academic Press Inc.), pp. 175-198

2016

  1. Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3

    Neuroscience, Vol. 339, pp. 191-209

2014

  1. Cannabinoids and the brain: New hopes for new therapies

    Cannabinoids (John Wiley and Sons Ltd), pp. 175-218

  2. Changes in CB1 and CB2 receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias

    British Journal of Pharmacology, Vol. 171, Núm. 6, pp. 1472-1489

  3. Endocannabinoid-hydrolysing enzymes in the post-mortem cerebellum of humans affected by hereditary autosomal dominant ataxias

    Pathobiology, Vol. 81, Núm. 3, pp. 149-159

2010

  1. Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders

    CNS Neuroscience and Therapeutics, Vol. 16, Núm. 3

2008

  1. Cannabinoid signaling system: does it play a function in cell proliferation and migration, neuritic elongation and guidance and synaptogenesis during brain ontogenesis?

    Cell adhesion & migration, Vol. 2, Núm. 4, pp. 246-248

  2. Colocalization of CB1 receptors with L1 and GAP-43 in forebrain white matter regions during fetal rat brain development: Evidence for a role of these receptors in axonal growth and guidance

    Neuroscience, Vol. 153, Núm. 3, pp. 687-699

2007

  1. An overview on the biochemistry of the cannabinoid system

    Molecular Neurobiology, Vol. 36, Núm. 1, pp. 3-14

  2. The activation of cannabinoid receptors during early postnatal development reduces the expression of cell adhesion molecule L1 in the rat brain

    Brain Research, Vol. 1145, Núm. 1, pp. 48-55

2004

  1. Behavioral and molecular changes elicited by acute administration of SR141716 to Δ 9 -tetrahydrocannabinol-tolerant rats: An experimental model of cannabinoid abstinence

    Drug and Alcohol Dependence, Vol. 74, Núm. 2, pp. 159-170

  2. Cannabinoids and gene expression during brain development

    Neurotoxicity Research, Vol. 6, Núm. 5, pp. 389-401

2003

  1. Prenatal cannabinoid and gene expression for neural adhesion molecule L1 in the fetal rat brain.

    Brain research. Developmental brain research, Vol. 147, Núm. 1-2, pp. 201-207

2002

  1. Exposure to cannabinoids in the development of endogenous cannabinoid system

    Neurotoxicity Research, Vol. 4, Núm. 4, pp. 363-372

2000

  1. Cannabinoid CB1 receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme

    Brain Research, Vol. 857, Núm. 1-2, pp. 56-65

  2. The endogenous cannabinoid system and brain development

    Trends in Neurosciences, Vol. 23, Núm. 1, pp. 14-20

1999

  1. Role of endocannabinoids in brain development

    Life Sciences, Vol. 65, Núm. 6-7, pp. 725-736

1998

  1. Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development

    Development, Vol. 125, Núm. 16, pp. 3179-3188

1997

  1. Atypical location of cannabinoid receptors in white matter areas during rat brain development

    Synapse, Vol. 26, Núm. 3, pp. 317-323